News

REGENATIVE LABS' STUDY OPENS THE DOOR FOR ADVANCED TREATMENT OF DEGENERATING TISSUE IN KNEE JOINTS
Regenative Labs announces groundbreaking Wharton's Jelly research demonstrating HCT/P compliance after processing
REGENATIVE LABS RELEASES NEW STUDY TO REVOLUTIONIZE TREATMENT FOR PATIENTS WITH DIABETIC FOOT ULCERS
REGENATIVE LABS AND AAPC ANNOUNCE COLLABORATION TO FURTHER HEALTHCARE COMPLIANCE
Institutional Review Board Approves Regenative Labs’ Protocol For Key Data Collection
Tyler Barrett, CEO of Regenative Labs
Regenative Labs Receives First National Medicare/Medicaid Insurance Reimbursement Approval for Wharton’s Jelly Allografts